It is important for our physicians to offer products that can be prescribed in the "Traditional and Complementary Medicine" field, which are safe, well-dosed, and in compliance with health standards. "Ruscus Aculaetus L.", the first product obtained in "Traditional Herbal Medicinal Product Development" project herbal root extract is a product indicated for venous circulatory disorders (vasoconstrictor).
Within the scope of the "Traditional Herbal Medicinal Product" regulation, the licensing works of the product have reached the last stage. The commercialization of the product will be carried out with ATABAY Chemical Industry and MAM cooperation project / licensing protocol agreement. With this contract, it is planned to apply for the license in September 2020 and commercial production in January 2021 With another protocol signed with Atabay drug, it has been foreseen that studies of 5 new plants can be performed besides Ruscus Aculeatus L. herbal root extract.